The LYCRA Company Marks First Anniversary as New Company
The LYCRA Company, a global leader in developing innovative solutions for the textile, apparel and personal care industries, is marking its first anniversary as a stand-alone subsidiary of the Ruyi Group on January 31.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200117005012/en/
Pictured: Shandong Ruyi Chairman, Yafu Qiu and The LYCRA Company CEO, Dave Trerotola (Photo: Business Wire)
In 2020, The LYCRA Company is operating at full strength across all facets of the organization and sharpening its focus to create value through strategic investments in science and technology as innovation is a key enabler to the company’s future success. The company is also actively exploring potential synergies with Ruyi, its majority shareholder, which include leveraging its spandex capacity and fully integrated value chain.
“Ruyi has been a strong partner that understood the challenges we faced as a new business, including the impact global economic trends had on our business performance,” said Dave Trerotola, CEO of The LYCRA Company. “This transition year also gave us plenty of wins as we built a strong foundation for future growth by continuing our heritage of investing in innovation.”
The LYCRA Company recently opened a new state-of-the-art research and development lab in Foshan, China, and launched several exciting new solutions designed to add value to collections and meet consumer needs for lasting comfort and performance.
The company expanded its EcoMade portfolio of sustainable products, broke new ground with its first print technology offering, and is ready to revolutionize apparel fit again with a new fiber that stretches to fit more body shapes within a size range. Products launched include:
- LYCRA® EcoMade fiber is the company’s first branded spandex that offers the same performance as the original LYCRA® fiber, but is made with pre-consumer recycled content.
- LYCRA® FitSense™ technology is a revolutionary water-based dispersion that is screen-printed onto garments to deliver lightweight, targeted support.
- LYCRA® MyFit™ fiber creates apparel with greater shape tolerance to offer consumers a customized fit experience.
- LYCRA HyFit® T859 fiber for personal care products is a new formulation that enables customers to have more run time per package. This results in improved uptime and reduced elastic consumption, as well as lower distribution and warehousing costs. It also helps customers meet sustainability goals.
Marketing highlights include many successful co-brand collaborations with esteemed brands and retailers, a robust global trade advertising program, and a 360-degree integrated marketing program to increase brand awareness and drive preference for LYCRA® fiber in China.
Looking ahead, The LYCRA Company has a robust innovation pipeline full of new and improved products to help it win in the marketplace. The company has also reaffirmed its commitment to its sustainability platform, Planet Agenda, which touches every aspect of the business from corporate responsibility and manufacturing excellence to product sustainability.
Customers can also expect The LYCRA Company to continue its principle-based approach to business, with its unwavering commitment to ethics and compliance.
“I’m really proud of everything we accomplished in our first year,” Trerotola concluded. “We’re very excited to be part of the Ruyi family and look forward to its ongoing support as we continue to transform our business and the apparel and personal care industries.”
About The LYCRA Company
The LYCRA Company innovates and produces fiber and technology solutions for the apparel and personal care industries, as well as specialty chemicals used in the spandex and polyurethane value chains. Headquartered in Wilmington, Delaware, The LYCRA Company is recognized worldwide for its innovative products, technical expertise, and unmatched marketing support. The LYCRA Company owns leading consumer and trade brands: LYCRA®, LYCRA HyFit®, LYCRA® T400®, L by LYCRA®, COOLMAX®, THERMOLITE®, ELASPAN®, SUPPLEX®, TACTEL®, and TERATHANE®. While The LYCRA Company’s name is new, its legacy stretches back to 1958 with the invention of the original spandex yarn, LYCRA® fiber. Today, The LYCRA Company is focused on adding value to its customers’ products by developing unique innovations designed to meet the consumer’s need for comfort and lasting performance. For more information, visit www.thelycracompany.com.
LYCRA®, LYCRA® FitSense™, LYCRA HyFit® and LYCRA® MyFit™ are trademarks of The LYCRA Company.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200117005012/en/
Contact information
Janeen Hill
Janeen.a.hill@lycra.com
(302) 683-3238
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Intends to Buy Back approximately 2.4 Million Shares in the Context of the Accelerated Bookbuild Offering by EQT, ADIA and Auba27.5.2025 18:46:00 EEST | Press release
Galderma Group AG (SWX:GALD): Ad hoc announcement pursuant to Art. 53 LR Galderma intends to repurchase approximately 2.4 million shares in the context of the accelerated bookbuild offering of Galderma shares by Sunshine SwissCo GmbH (“EQT”), Abu Dhabi Investment Authority (“ADIA”) and Auba Investment Pte. Ltd. (“Auba”) announced today The repurchased shares will be held in treasury and financed by existing liquidity at hand Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that it intends to repurchase approximately 2.4 million Galderma shares in the context of an accelerated bookbuilding offering (“ABO”) of approximately 16.7 million Galderma shares (approximately 7% of Galderma’s share capital) by EQT, ADIA and Auba. Galderma will participate in the ABO at the same price per share which will be determined in the bookbuilding. The repurchased shares will be financed by Galderma’s existing liquidity on hand and will not affect the company’s ability to de
New South Wales Minister for Industry and Trade Visits Novotech Seoul Office to Strengthen Clinical Trial Collaboration27.5.2025 18:44:00 EEST | Press release
Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory company trusted by biotech and small- to mid-sized pharmaceutical companies to guide drug development at every phase, was honored to welcome The Hon. Anoulack Chanthivong, New South Wales (NSW) Minister for Industry and Trade, to its Seoul office on May 19. The Minister’s visit highlights a deepening collaboration between South Korea and Australia in the field of clinical research and highlights the strategic importance of cross-border partnerships in advancing global drug development. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250527294947/en/ Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory company trusted by biotech and small- to mid-sized pharmaceutical companies to guide drug development at every phase, was honored to welcome The Hon. Anoulack Chanthivong,
LambdaTest Introduces Automation MCP Server to Revolutionize Test Failure Triaging27.5.2025 18:00:00 EEST | Press release
LambdaTest, a unified agentic AI and cloud engineering platform, has announced the launch of its Automation MCP Server, a breakthrough solution designed to simplify and accelerate the process of triaging test failures. By enabling direct integration between AI assistants and LambdaTest’s test execution data, the Automation MCP Server empowers developers and QA engineers to investigate and resolve issues faster, without leaving their integrated development environment (IDE). The Automation MCP Server offers a seamless interface within the IDE, allowing users to access and analyze real-time test data with ease. With intelligent root cause analysis, the MCP server can quickly identify the underlying reasons for test failures and take immediate action to fix the underlying code. This results in fewer debugging cycles and faster release times. The server also enhances automated testing workflows by enabling the generation of new test cases using real execution data. Developers can leverage
The Six Winning Projects of the 12 th Edition of the IBSA Foundation Fellowships have been Awarded and the 2025 Call is Now Open27.5.2025 17:58:00 EEST | Press release
Research means investing in the future. This is the guiding principle behind the IBSA Foundation Fellowships programme, which for over a decade has supported talented researchers under 40 from universities and research institutions around the world. The programme awards grants to promote innovative and potentially groundbreaking projects in lesser-explored scientific fields; a constantly growing success, also confirmed by the 2024 edition, which marked a new record, with 259 applications across five scientific areas. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250522244202/en/ The Award Ceremony of the 12th edition of the IBSA Foundation Fellowship The € 32,000 fellowships were awarded to research projects in five scientific areas: dermatology, endocrinology, fertility/urology, pain medicine/orthopaedics/rheumatology and healthy aging/regenerative medicine. In particular, this latter category has attracted growing interes
Rigaku Completes New Building at Yamanashi Plant27.5.2025 17:00:00 EEST | Press release
Rigaku Corporation, a global solution partner in X-ray analytical technologies and a Group company of Rigaku Holdings Corporation (headquarters: Akishima, Tokyo; President and CEO: Jun Kawakami; hereinafter “Rigaku”) completed an additional manufacturing building (hereinafter “the New Building”) at Yamanashi Plant, Rigaku’s main production facility. The facility was established to serve as the center of Rigaku’s production framework, in anticipation of global business growth and expansion in product demand. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250527974928/en/ Exterior view of the New Building, Yamanashi Plant Doubling of production capacity: a strategic base to support Rigaku’s growth Demand for X-ray analytical solutions has soared in recent years, both in Japan and worldwide. To respond to growing demand, Rigaku implemented this expansion with two key objectives in mind. One objective is to further reinforce the
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom